These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2839326)

  • 21. [Angiotensin converting enzyme inhibitory activity of MK-0521 in vivo and antihypertensive effect of its single oral administration on blood pressure and effect on the renin-angiotensin system in 2-kidney Goldblatt hypertensive dogs].
    Oda M; Ino Y; Suzuki K; Sato T; Iwamoto S; Iwaki M
    Nihon Yakurigaku Zasshi; 1989 Apr; 93(4):225-34. PubMed ID: 2545579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of lisinopril.
    Beermann B
    Am J Med; 1988 Sep; 85(3B):25-30. PubMed ID: 2844083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical experience and rationale for angiotensin-converting enzyme inhibition with lisinopril as the initial treatment for hypertension in older patients.
    Pool JL; Nelson EB; Taylor AA
    Am J Med; 1988 Sep; 85(3B):19-24. PubMed ID: 2844082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACE inhibition and pressor responsiveness to norepinephrine in hypertensive patients.
    Malini PL; Strocchi E; Valtancoli G; Ambrosioni E
    J Clin Pharmacol; 1990 May; 30(5):422-4. PubMed ID: 2161435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lisinopril in hypertensive patients with and without renal failure.
    van Schaik BA; Geyskes GG; Boer P
    Eur J Clin Pharmacol; 1987; 32(1):11-6. PubMed ID: 3034622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlling hypertension: lisinopril-hydrochlorothiazide vs captopril-hydrochlorothiazide. An Italian multicentre study.
    Rappelli A
    J Hum Hypertens; 1991 Dec; 5 Suppl 2():55-7; discussion 57-8. PubMed ID: 1665178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lisinopril in essential hypertension: a six month comparative study with nifedipine.
    Richardson PJ; Meany B; Breckenridge AM; Grimmer SF; Johnston GD; Kondowe G
    J Hum Hypertens; 1987 Dec; 1(3):175-9. PubMed ID: 2852252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
    Gosse P; Dallocchio M; Gourgon R
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():23-8. PubMed ID: 2550642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of lisinopril in older patients with essential hypertension.
    Gomez HJ; Smith SG; Moncloa F
    Am J Med; 1988 Sep; 85(3B):35-7. PubMed ID: 2844085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lisinopril versus lisinopril plus hydrochlorothiazide in essential hypertension.
    Mehta J; Lopez LM; Thorman AD
    Am J Cardiol; 1988 Apr; 61(10):803-6. PubMed ID: 2833090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once-daily lisinopril compared with twice-daily captopril in the treatment of mild to moderate hypertension: assessment of office and ambulatory blood pressures.
    Whelton A; Miller WE; Dunne B; Hait HI; Tresznewsky ON
    J Clin Pharmacol; 1990 Dec; 30(12):1074-80. PubMed ID: 2177062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
    Karlberg BE; Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Ohman KP
    Scand J Urol Nephrol Suppl; 1984; 79():103-6. PubMed ID: 6089307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lisinopril, a new angiotensin converting enzyme inhibitor.
    Arzubiaga C; Beck NA
    Am J Med Sci; 1992 May; 303(5):340-4. PubMed ID: 1316080
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy and safety of spirapril in mild-to-moderate hypertension.
    Hayduk K; Kraul H
    J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 1():S19-23. PubMed ID: 10499560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience with lisinopril. Observations on safety and tolerability.
    Cameron HA; Higgins TJ
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():177-86. PubMed ID: 2550641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Captopril administered every three hours in difficult-to-control hypertension.
    Vardan S; Mookherjee S; Smulyan H
    Chest; 1992 Jul; 102(1):303-4. PubMed ID: 1320565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind comparison of lisinopril with captopril in patients with symptomatic congestive heart failure.
    Powers ER; Chiaramida A; DeMaria AN; Giles TD; Hackshaw B; Hart W; Haugland M; Johnston R; Katz R; Kirlin P
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S82-8. PubMed ID: 2442559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lisinopril: a review of its use in congestive heart failure.
    Simpson K; Jarvis B
    Drugs; 2000 May; 59(5):1149-67. PubMed ID: 10852646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responses.
    Uretsky BF; Shaver JA; Liang CS; Amin D; Shah PK; Levine TB; Walinsky P; LeJemtel T; Linnemeier T; Rush JE
    Am Heart J; 1988 Aug; 116(2 Pt 1):480-8. PubMed ID: 2840815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.